Summary
Centene Corporation announced on February 23, 2022, that its CEO, Chairman, and Director, Michael Neidorff, has been granted a paid medical leave of absence. This transition marks a significant leadership change for the company. In response to Mr. Neidorff's leave, the Board of Directors has appointed an interim leadership structure. James Dallas has been named Acting Chairman of the Board. Furthermore, an expanded Office of the Chairman has been established, comprising Sarah London (Vice Chairman), Brent Layton (President and COO), Drew Asher (CFO), and Shannon Bagley (Chief Administrative Officer). This expanded office will collectively manage the company's day-to-day operations and fulfill the CEO's duties on an interim basis, reporting to the Acting Chairman. The company also confirmed that its previously announced CEO succession process is ongoing and expected to conclude by the second quarter of 2022.
Key Highlights
- 1CEO Michael Neidorff is taking a paid medical leave of absence.
- 2James Dallas appointed Acting Chairman of the Board.
- 3An expanded Office of the Chairman, including Sarah London, Brent Layton, Drew Asher, and Shannon Bagley, will manage day-to-day operations on an interim basis.
- 4The interim leadership team will report to the Acting Chairman.
- 5The CEO succession process is proceeding and is targeted for completion by Q2 2022.
- 6This announcement was made via an 8-K filing on February 24, 2022.